(UroToday.com) The 2025 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting held in New Orleans, LA, between June 21 st and 24 th, 2025, was host to the Barry Siegel Award Lecture ...

Alicia Morgans: I am going to be talking about incorporating PSMA PETs into registration trials with an example of a study that is relying on a PSMA PET endpoint as the primary endpoint in the study.

David Matheson discusses the patient perspective on radiographic progression-free survival as a clinical trial endpoint. Dr. Matheson argues that imaging-based progression is more ...

Tyler Seibert outlines his approach to radiation therapy for the primary tumor in metastatic hormone-sensitive prostate cancer. He summarizes three randomized trials that consiste ...

Age 18 and older Confirmed diagnosis of prostate cancer Men receiving standard-of-care ADT either for high-risk, locally advanced prostate cancer or as a part of multicomponent management of ...

Silke Gillessen speaks with Neeraj Agarwal about the Advanced Prostate Cancer Consensus Conference, marking its 10th anniversary edition in Lugano. Dr. Gillessen describes APCCC's focus on daily ...

Matthew Cooperberg speaks with Martin Gleave about GUNS, a neoadjuvant adaptive umbrella trial for men with high-volume, high-grade prostate cancer. Now at 280 patients enrolled, GUNS sequences needle ...

UroToday - GU OncToday brings coverage of the clinically relevant content needed to stay at the forefront of the dynamic field of GU oncology and urology.

Sophia Coraci discusses an analysis of 104 treatment-naive prostate cancer patients correlating PSMA PET SUVmax with Decipher genomic classifier scores. PSMA PET imaging occurred within 35 days of ...

Ananya Choudhury reviews radiation therapy for non-muscle invasive bladder cancer, citing 1990s UK trials showing overlapping Kaplan-Meier curves between radiotherapy and standard care. Modern ...

UroToday - GU OncToday brings coverage of the clinically relevant content needed to stay at the forefront of the dynamic field of GU oncology and urology.

Low-Intensity Shockwave Therapy (LiSWT) has emerged as a safe, non-invasive treatment option for erectile dysfunction. Reports regarding efficacy are heterogeneous at best, and both the AUA (American ...